The Latest Breaking News from Mizuho

Palantir stock has delivered market-beating returns to shareholders in the last 12 months. However, its steep valuation suggests the tech stock might trail the broader markets if sentiment turns bearish.

Despite Palantir's impressive 66% surge this year, Mizuho downgraded the stock to 'Underperform' due to concerns over high valuation and limited earnings visibility. With mixed analyst ratings and the Q2 earnings report approaching, investors are advised to tread carefully and prepare for potential volatility.

Brokerage firm Mizuho says this energy stock sits at the 'data center crossroads' of America - which is a good spot to be right now, as AI drives an exponential surge in energy demand.

Amid expectations for higher oil demand from JPMorgan, here are 5 top-rated stocks from the energy sector with plenty of upside potential.

Japan-based financial institution is the latest foreign firm to apply to establish a wholly owned brokerage

Sunoco has been upgraded by multiple analysts who think the stock's recent pullback is overdone, with upcoming management guidance and the NuStar acquisition expected to be positive catalysts for the energy name.

Korda became the fastest player to reach $2 million in a single LPGA season.

AES Corporation has underperformed the broader market YTD, but Wall Street analysts are highly optimistic about the stock’s prospects.

Among world’s top 60 banks those in US are biggest fossil fuel financiers, while Barclays leads way in Europe

Integrating juniors was the plan from the start for this purpose-driven event.

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to combat obesity. Is TERN stock a good buy right now?